|Articles|May 11, 2021
Nitrosamine impurities in Sartan drug products by GC-MS/MS
Author(s)Shimadzu Corporation
This application demonstrates a reliable GC–MS/MS method for analysis of nitrosamine drug products including the three impurities NDMA, NDEA, and NDBA listed by US FDA.
Newsletter
Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.
Related Content
Trending on LCGC International
1
Thermo Fisher and NVIDIA Partner to Expand AI Driven Laboratory Automation
2
Rapid Native HIC–MS Using Ammonium Tartrate for Robust Drug-to-Antibody Ratio Characterization of Antibody–Drug Conjugates
3
Waters Corporation Shareholders Approve Share Issuance for Planned Combination with BD Biosciences and Diagnostics
4
Isotope Dilution HPLC–MS/MS Analysis of Serum Cotinine Reveals Environmental Tobacco Smoke–Associated PID Risk
5